TipRanks
Advertisement
Advertisement

GB:SCLP Stock Latest News

Scancell Secures Up to US$25m BlackRock Debt to Drive iSCIB1+ Phase 3
Company AnnouncementsScancell Secures Up to US$25m BlackRock Debt to Drive iSCIB1+ Phase 3
3d ago
Scancell’s Phase 3 Melanoma Vaccine Trial Moves Toward Launch, Raising Long-Term Upside Questions
PremiumCompany Announcements
Scancell’s Phase 3 Melanoma Vaccine Trial Moves Toward Launch, Raising Long-Term Upside Questions
15d ago
SCLP
Scancell to Highlight Late-Stage Cancer Immunotherapy and U.S. Deal Plans at Wainwright Conference
PremiumCompany Announcements
Scancell to Highlight Late-Stage Cancer Immunotherapy and U.S. Deal Plans at Wainwright Conference
24d ago
Scancell Wins UK Green Light for Global Phase 3 Melanoma Trial of iSCIB1+
PremiumCompany Announcements
Scancell Wins UK Green Light for Global Phase 3 Melanoma Trial of iSCIB1+
1M ago
Scancell Extends CSO Share Option Exercise Period
PremiumCompany Announcements
Scancell Extends CSO Share Option Exercise Period
2M ago
Scancell Raises £15.7m After Oversubscribed Retail Offer and UK Placing
PremiumCompany AnnouncementsScancell Raises £15.7m After Oversubscribed Retail Offer and UK Placing
2M ago
Scancell and Neuphoria in all-share merger backed by $89m financing for melanoma trial
Premium
Company Announcements
Scancell and Neuphoria in all-share merger backed by $89m financing for melanoma trial
2M ago
Scancell upsizes oversubscribed £13m UK placing to extend funding runway
Premium
Company Announcements
Scancell upsizes oversubscribed £13m UK placing to extend funding runway
2M ago
Scancell launches discounted UK share placing to fund Phase 3 melanoma trial
PremiumCompany Announcements
Scancell launches discounted UK share placing to fund Phase 3 melanoma trial
2M ago
Scancell launches retail offer and placing to extend cash runway into 2027
PremiumCompany Announcements
Scancell launches retail offer and placing to extend cash runway into 2027
2M ago
Scancell to Merge with Neuphoria and Secure Up to $89m for Phase 3 Melanoma Trial
PremiumCompany Announcements
Scancell to Merge with Neuphoria and Secure Up to $89m for Phase 3 Melanoma Trial
2M ago
Scancell in advanced talks on Neuphoria reverse merger and Nasdaq listing
PremiumCompany Announcements
Scancell in advanced talks on Neuphoria reverse merger and Nasdaq listing
3M ago
Scancell Wins FDA Fast Track for Melanoma Vaccine as Phase 2 Data Strengthen
PremiumCompany AnnouncementsScancell Wins FDA Fast Track for Melanoma Vaccine as Phase 2 Data Strengthen
5M ago
Scancell Taps Veteran Biotech Financier as Interim CFO Amid iSCIB1+ Push
Premium
Company Announcements
Scancell Taps Veteran Biotech Financier as Interim CFO Amid iSCIB1+ Push
6M ago
Scancell Holdings Charts Risky but Promising Phase III Path
Premium
Company Announcements
Scancell Holdings Charts Risky but Promising Phase III Path
8M ago
Scancell Secures FDA Green Light for Phase 3 Melanoma Trial as Pipeline and Cash Runway Advance
PremiumCompany Announcements
Scancell Secures FDA Green Light for Phase 3 Melanoma Trial as Pipeline and Cash Runway Advance
8M ago
Scancell Wins FDA Nod for Phase 3 Melanoma Trial of iSCIB1+ After Strong Phase 2 Data
PremiumCompany Announcements
Scancell Wins FDA Nod for Phase 3 Melanoma Trial of iSCIB1+ After Strong Phase 2 Data
8M ago
Scancell Sets Date for Interim Results as Cancer Immunotherapy Portfolio Advances
PremiumCompany Announcements
Scancell Sets Date for Interim Results as Cancer Immunotherapy Portfolio Advances
8M ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
PremiumCompany Announcements
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Trial
10M ago
Scancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
PremiumCompany AnnouncementsScancell’s iSCIB1+ Shows Promising Results in Melanoma Treatment
11M ago
Scancell Holdings Successfully Passes AGM Resolutions
Premium
Company Announcements
Scancell Holdings Successfully Passes AGM Resolutions
11M ago
Scancell’s Modi-1 Moditope Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Scancell’s Modi-1 Moditope Study: A Potential Game-Changer in Cancer Treatment
11M ago
SCLP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >